StockData
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31

BillionToOne, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$101.03+2.91 (+2.97%)

Close on Oct 19, 2026

Market cap
$5.50B
P/E (TTM)
721.6
Dividend yield
–

Earnings

Next report expected Dec 8, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 5, 2026After market close$109.40M$0.15–
Q1 FY2026
Ended Mar 31, 2026
May 6, 2026After market close$108.40M$0.34–
Q4 FY2025
Ended Dec 31, 2025
Mar 4, 2026After market close$96.10M$0.11–
Q3 FY2025
Ended Sep 30, 2025
Dec 9, 2025After market close$83.50M$0.10–

Company guidance

Outlook given with results on Aug 5, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
growthfull year 202648% to 52% growthMaintained
total revenuefull year 2026$450.00M to $465.00MMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements BillionToOne filed with the SEC